Markets:

Overview

News

Currencies

International

Treasuries

Redhill Biopharma Ltd. - American Depositary Shares (NQ:RDHL)

0.7201 +0.0271 (+3.91%)

Streaming Delayed Price Updated: 9:31 AM EDT, Jul 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Redhill Biopharma Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Get insights into the top gainers and losers of Friday's after-hours session. ↗

June 12, 2026

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

January 05, 2026

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

Why Intuitive Surgical Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket ↗

October 22, 2025

Via Benzinga

RedHill Biopharma Logs Best Session In Over A Year After $10M Legal Victory — Retail Sees Bullish Triggers Ahead ↗

September 29, 2025

Via Stocktwits

Why Is RedHill Biopharma (RDHL) Stock Up 75% Today? ↗

August 01, 2024

One of today's biggest market movers in the biotech space is RedHill Biuopharma, with RDHL stock up more than 75% on big news.

Via InvestorPlace

Wondering what's happening in today's pre-market session? ↗

September 29, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 29, 2025

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 13, 2025

Via Benzinga

Get insights into the top gainers and losers of Monday's after-hours session. ↗

July 21, 2025

The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

Which stocks are experiencing notable movement on Monday? ↗

July 21, 2025

Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 18, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 18, 2025

Via Benzinga

Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket ↗

July 18, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 21, 2025

Via Benzinga

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

April 17, 2025

Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.

Via Chartmill

Which stocks are moving after the closing bell on Wednesday? ↗

April 16, 2025

Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 13, 2025

Via Benzinga

New Prostate Cancer Hope? Bayer-Funded Phase 2 Study To Test Combination Of RedHill's Opaganib And Bayer’s Darolutamide, To Overcome Androgen Resistance

February 05, 2025

New Prostate Cancer Hope? Bayer-Funded Phase 2 Study To Test Combination Of RedHill's Opaganib And Bayer’s Darolutamide, To Overcome Androgen Resistance

Via News Direct

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 21, 2025

Via Benzinga

Supreme Court Of New York Awards RedHill Biopharma Approx. $8 Million Plus Costs In Breach Of Contract Lawsuit

December 09, 2024

Supreme Court Of New York Awards RedHill Biopharma Approx. $8 Million Plus Costs In Breach Of Contract Lawsuit

Via News Direct

Topics Lawsuit

RedHill Biopharma Secures U.S. Government Funding Through BARDA To Advance Opaganib For Ebola Treatment

October 15, 2024

RedHill Biopharma Secures U.S. Government Funding Through BARDA To Advance Opaganib For Ebola Treatment

Via News Direct

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 03, 2024

Via Benzinga

RedHill's Opaganib Shows Diabetes And Obesity Potential With Positive In Vivo Results

August 23, 2024

RedHill's Opaganib Shows Diabetes And Obesity Potential With Positive In Vivo Results

Via News Direct

Israel-Based RedHill's Investigational COVID-19 Treatment Shows Encouraging Action In Obesity And Diabetes ↗

August 19, 2024

RedHill Biopharma released study results showing opaganib's potential in treating Type 2 diabetes and obesity. The drug's ability to target sphingolipid metabolism could help prevent weight gain and...

Via Benzinga

Crude Oil Moves Lower; Moderna Shares Plunge ↗

August 01, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.